Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07424781

Fluoxetine on Emotional Experience (FLEX) Study

The Effect of Fluoxetine Treatment on Anger Processing in Healthy Young People

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years – 24 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical medicine study is to investigate how does antidepressant fluoxetine modulate anger processing in healthy young people . The main questions it aims is to answer are: 1. How does fluoxetine affect responses to anger-related stimuli such as words, faces, and autobiographical recall? 2. How does fluoxetine influence responses during frustration induction in frustrative non-reward and threat paradigms? 3. Does the effect manifest in physiological markers, including heart rate variability and facial expressions? Researchers will compare fluoxetine to a placebo to see if drug fluoxetine affects anger processing. Participants will: Take 20mg fluoxetine or a placebo every day for 7 days. Visit the university site for questionnaire and tasks assessments. Heart rate variability and facial expressions will be recorded in some of the tasks.

Conditions

Interventions

TypeNameDescription
DRUGFluoxetineParticipants will receive 20mg of fluoxetine daily for 7 days. Tablets encapsulated to aid blinding.
DRUGPlaceboParticipants will receive one dose placebo (sucrose) daily for 7 days. Tablets encapsulated to aid blinding.

Timeline

Start date
2025-10-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-02-20
Last updated
2026-02-20

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07424781. Inclusion in this directory is not an endorsement.